Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme

Progress in the treatment of glioblastoma multiforme (GBM) over the last few decades has remained marginal and GBM is still universally fatal with short survival times after initial diagnosis. Much research is focused on finding new therapeutics for GBM and immune based approaches have shown great p...

Full description

Bibliographic Details
Main Authors: Andrea eSchuessler, David eWalker, Rajiv eKhanna
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00275/full
_version_ 1819259645729964032
author Andrea eSchuessler
David eWalker
Rajiv eKhanna
author_facet Andrea eSchuessler
David eWalker
Rajiv eKhanna
author_sort Andrea eSchuessler
collection DOAJ
description Progress in the treatment of glioblastoma multiforme (GBM) over the last few decades has remained marginal and GBM is still universally fatal with short survival times after initial diagnosis. Much research is focused on finding new therapeutics for GBM and immune based approaches have shown great promise. The detection of cytomegalovirus (CMV) antigens in malignant cells has suggested that treatment strategies based on immunological intervention, such as adoptive transfer of antiviral T cells or vaccination with viral epitopes, could be exploited as cancer therapy. We review here the rationale for using CMV as a therapeutic target and discuss the first clinical evidence for safety and efficacy of CMV specific cellular immunotherapy for GBM.
first_indexed 2024-12-23T19:13:18Z
format Article
id doaj.art-6e988d7b0a0c4e4b9c39cd87e875e6c5
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-23T19:13:18Z
publishDate 2014-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-6e988d7b0a0c4e4b9c39cd87e875e6c52022-12-21T17:34:23ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2014-10-01410.3389/fonc.2014.00275112214Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiformeAndrea eSchuessler0David eWalker1Rajiv eKhanna2QIMR Berghofer Medical Research InstituteNewro FoundationQIMR Berghofer Medical Research InstituteProgress in the treatment of glioblastoma multiforme (GBM) over the last few decades has remained marginal and GBM is still universally fatal with short survival times after initial diagnosis. Much research is focused on finding new therapeutics for GBM and immune based approaches have shown great promise. The detection of cytomegalovirus (CMV) antigens in malignant cells has suggested that treatment strategies based on immunological intervention, such as adoptive transfer of antiviral T cells or vaccination with viral epitopes, could be exploited as cancer therapy. We review here the rationale for using CMV as a therapeutic target and discuss the first clinical evidence for safety and efficacy of CMV specific cellular immunotherapy for GBM.http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00275/fullAdoptive TransferCytomegalovirusImmunotherapyT cellglioblastoma multiforme (GBM)checkpoint modulators
spellingShingle Andrea eSchuessler
David eWalker
Rajiv eKhanna
Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
Frontiers in Oncology
Adoptive Transfer
Cytomegalovirus
Immunotherapy
T cell
glioblastoma multiforme (GBM)
checkpoint modulators
title Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
title_full Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
title_fullStr Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
title_full_unstemmed Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
title_short Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
title_sort cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
topic Adoptive Transfer
Cytomegalovirus
Immunotherapy
T cell
glioblastoma multiforme (GBM)
checkpoint modulators
url http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00275/full
work_keys_str_mv AT andreaeschuessler cytomegalovirusasanoveltargetforimmunotherapyofglioblastomamultiforme
AT davidewalker cytomegalovirusasanoveltargetforimmunotherapyofglioblastomamultiforme
AT rajivekhanna cytomegalovirusasanoveltargetforimmunotherapyofglioblastomamultiforme